These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10605955)

  • 1. Fibrinogen Milano XIII (Aalpha 19 Arg-->Gly): a dysfunctional variant with an amino acid substitution in the N-terminal polymerization site.
    Bolliger-Stucki B; Bucciarelli P; Lämmle B; Furlan M
    Thromb Res; 1999 Dec; 96(5):399-405. PubMed ID: 10605955
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B; Lord ST; Furlan M
    Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Saint-Germain I: a case of the heterozygous Aalpha GLY 12 --> VAL fibrinogen variant.
    Mathonnet F; Peltier JY; Detruit H; de Raucourt E; Alvarez JC; Mazmanian GM; de Mazancourt P
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):149-53. PubMed ID: 11914657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
    Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
    Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.
    Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA
    Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
    Seydewitz HH; Gram J; Bruhn HD; Witt I
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
    Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
    Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
    Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain.
    Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.